Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-05-03

FDA Approved: BUSPIRONE HYDROCHLORIDE — Original Application (APNAR PHARMA LP)

View source ↗

Summary

The FDA approves an original ANDA for buspirone hydrochloride from APNAR PHARMA LP, enabling a generic version of buspirone to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buspirone hydrochloride (buspirone hydrochloride)

Snippet

ORIG AP for BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)